Wall Street brokerages forecast that Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Rating) will announce $6.31 million in sales for the current quarter, Zacks reports. Two analysts have made estimates for Tango Therapeutics’ earnings, with estimates ranging from $6.13 million to $6.50 million. The firm is scheduled to announce its next quarterly earnings report on Monday, […]
Tango Therapeutics (NASDAQ:TNGX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as […]
Tango Therapeutics (NASDAQ:TNGX – Get Rating) issued its earnings results on Monday. The company reported ($0.25) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.26) by $0.01, MarketWatch Earnings reports. TNGX traded up $0.12 on Wednesday, reaching $7.15. The company’s stock had a trading volume of 481,572 shares, compared to […]
Tango Therapeutics Inc (NASDAQ:TNGX – Get Rating)’s stock price was down 4.6% on Friday . The company traded as low as $7.93 and last traded at $7.95. Approximately 8,484 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 184,057 shares. The stock had previously closed at $8.33. Separately, […]
Analysts expect Tango Therapeutics Inc (NASDAQ:TNGX – Get Rating) to post earnings of ($0.27) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Tango Therapeutics’ earnings. The highest EPS estimate is ($0.25) and the lowest is ($0.28). The firm is expected to announce its next quarterly […]